As weight‑loss drugs surge in popularity, a study raises a new question about what patients may be losing along the way.

President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...

GLP-1 drugs, especially those containing semaglutide, were associated with fewer psychiatric-related hospital visits and ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...

The move to ease restrictions into researching the drug are part of a broader push for scientists to study the therapeutic ...

Researchers at The University of Manchester have identified a range of key risk and protective factors influencing whether ...

Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.